Cantor Fitzgerald reissued their overweight rating on shares of Prothena (NASDAQ:PRTA – Free Report) in a research report ...
Equities researchers at Cantor Fitzgerald upped their FY2025 earnings per share estimates for shares of Enovix in a research report issued on Thursday, February 20th. Cantor Fitzgerald analyst D.
Evercore ISI analyst Peter Levine maintained a Buy rating on Five9 (FIVN – Research Report) on February 21 and set a price target of $55.00.